Extrachromosomal DNA Associates with Nuclear Condensates and Reorganizes Chromatin Structures to Enhance Oncogenic Transcription

Aziz Taghbalout,Chia-Hao Tung,Patricia A Clow,Ping Wang,Harianto Tjong,Chee Hong Wong,Diane D Mao,Rahul Maurya,Meng-Fan Huang,Chew Yee Ngan,Albert H Kim,Chia-Lin Wei

DOI: https://doi.org/10.1101/2024.09.17.613488

2024-09-20

Abstract:Extrachromosomal, circular DNA (ecDNA) is a prevalent oncogenic alteration in cancer genomes, often associated with aggressive tumor behavior and poor patient outcome. While previous studies proposed a chromatin-based mobile enhancer model for ecDNA-driven oncogenesis, its precise mechanism and impact remains unclear across diverse cancer types. Our study, utilizing advanced multi-omics profiling, epigenetic editing, and imaging approaches in three cancer models, reveals that ecDNA hubs are an integrated part of nuclear condensates and exhibit cancer-type specific chromatin connectivity. Epigenetic silencing of the ecDNA-specific regulatory modules or chemically disrupting liquid-liquid phase separation breaks down ecDNA hubs, displaces MED1 co-activator binding, inhibits oncogenic transcription, and promotes cell death. These findings substantiate the trans-activator function of ecDNA and underscore a structural mechanism driving oncogenesis. This refined understanding expands our views of oncogene regulation and opens potential avenues for novel therapeutic strategies in cancer treatment.

Genomics

What problem does this paper attempt to address?

The problem this paper attempts to address is: How does extrachromosomal DNA (ecDNA) enhance oncogenic transcription in cancer genomes by forming nuclear condensates and reorganizing chromatin structure?

Specifically, the researchers aim to answer this question through the following points:

1. **The relationship between ecDNA and nuclear condensates**: Investigate whether ecDNA is part of nuclear condensates and how these condensates are formed through liquid-liquid phase separation (LLPS).
2. **The impact of ecDNA on chromatin structure**: Analyze how ecDNA affects the 3D structure of chromatin, particularly how it enhances the transcription of oncogenes through specific chromatin interactions.
3. **The transcriptional regulatory mechanism of ecDNA**: Reveal how ecDNA promotes the expression of oncogenes by interacting with chromatin genes through its unique regulatory modules, such as super-enhancers.
4. **Validation of ecDNA function**: Validate the function of ecDNA in cancer cells and its impact on cell survival and proliferation through methods such as chemical interference and epigenetic editing.

Through these studies, the paper aims to provide a comprehensive understanding of how ecDNA acts as a mobile transcriptional activator in various types of cancer and to offer a theoretical basis for the further development of therapeutic strategies targeting ecDNA.